Omandam, Neo Anderson .

HRN: 24-18-75  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/01/2026
05/08/2026
IV
3.5g
Q6H
PCAP
Remove - Pending Acceptance
05/01/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/01/2026
05/08/2026
IV
240mg
Q6h
PCAP
Remove - Pending Acceptance
05/01/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/01/2026
05/08/2026
IV
900mg
Q8
PCAP-C With Plerural Effusion
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: